RBC
MDT icon

Ronald Blue & Co’s Medtronic MDT Stock Holding History

Ronald Blue & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,745
Closed -$221K – 257
2017
Q1 		$221K Buy
+2,745
New +$214K 0.01% 192
2015
Q4 		– Sell
-7,910
Closed -$529K – 257
2015
Q3 		$529K Sell
7,910
-1,220
-13% -$89.9K 0.03% 137
2015
Q2 		$676K Buy
9,130
+3,318
+57% +$254K 0.03% 124
2015
Q1 		$453K Buy
+5,812
New +$441K 0.02% 186
2014
Q2 		– Sell
-3,252
Closed -$200K – 347
2014
Q1 		$200K Sell
3,252
-1,515
-32% -$88.2K 0.01% 305
2013
Q4 		$274K Buy
4,767
+222
+5% +$12.6K 0.02% 228
2013
Q3 		$242K Buy
+4,545
New +$245K 0.02% 222

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Ronald Blue & Co's MDT Position: Q2 2017 in Review

Ronald Blue & Co sold out of Medtronic (MDT) in Q2 2017, closing a stake of 2,745 shares — an estimated $221K sold.

Ronald Blue & Co first reported a position in MDT in Q3 2013 and held it in 7 quarters. The position peaked at $676K in Q2 2015. 1,281 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Ronald Blue & Co reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Ronald Blue & Co sold 2,745 Medtronic shares in Q2 2017, an estimated $221K.
  • Ronald Blue & Co first reported a position in Medtronic in Q3 2013 and held it in 7 quarters.
  • Ronald Blue & Co's Medtronic position peaked at $676K in Q2 2015.
  • 1,281 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.